Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Tommaso Gori

Mainz, RP, DE 
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Tommaso Gori practices in Mainz, Germany. Mr. Gori is rated as an Experienced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Coronary Heart Disease, Prinzmetal's Variant Angina, Angina, Percutaneous Coronary Intervention (PCI), and Angioplasty.

His clinical research consists of co-authoring 309 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Mainz, RP, Germany
Other Locations
NI, Germany
Hamburg, HH, Germany
Goettingen, NI, Germany
Frankfurt Am Main, HE, Germany
Berlin, BE, Germany
Rhein, NW, Germany
Gutenberg, RP, Germany
Greifswald, MV, Germany
Hirschhorn, RP, Germany
Munich, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions
QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Device, Diagnostic test
Study Phase: Phase 4
Treatment of Coronary Bifurcation Lesions: a Non-inferiority, Randomized, Controlled Procedural Outcomes Trial Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting
Treatment of Coronary Bifurcation Lesions: a Non-inferiority, Randomized, Controlled Procedural Outcomes Trial Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
MACCUS: ModulAtion of Cardiac Coronary Sinus Hemodynamics to Develop a New Treatment for microvascUlar diseaSe. A Single Center, Randomized Study.
MACCUS: ModulAtion of Cardiac Coronary Sinus Hemodynamics to Develop a New Treatment for microvascUlar diseaSe. A Single Center, Randomized Study.
Enrollment Status: Completed
Publish Date: August 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
Implantable Cardiac Monitors in High-risk Post-infarction Patients With Cardiac Autonomic Dysfunction and Moderately Reduced Left Ventricular Ejection Fraction
Implantable Cardiac Monitors in High-risk Post-infarction Patients With Cardiac Autonomic Dysfunction and Moderately Reduced Left Ventricular Ejection Fraction
Enrollment Status: Completed
Publish Date: June 23, 2021
Intervention Type: Device
Study Phase: Not Applicable
XIENCE 28 Global Study
XIENCE 28 Global Study
Enrollment Status: Completed
Publish Date: March 04, 2021
Intervention Type: Drug, Device
Study Phase: Not Applicable
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Enrollment Status: Completed
Publish Date: April 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

309 Total Publications

Equal tools, unequal tolls: should sex influence decision-making for aortic valve stenosis?
Equal tools, unequal tolls: should sex influence decision-making for aortic valve stenosis?
Journal: European heart journal
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gori's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile